Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive nonsyndromic deafness in which the cause of the disease is a mutation in the SERPINB6 gene.
Features include: Progressive hearing impairment.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Progressive hearing impairment |
SERPINB6 function has not been fully characterized.
Autosomal recessive nonsyndromic hearing loss 91 is associated with mutations in the SERPINB6 gene on chromosome 6.
Genetic testing for SERPINB6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive nonsyndromic hearing loss 91 has been reported in the published literature.
No clinical trials have been registered for autosomal recessive nonsyndromic hearing loss 91.
2 publications have been identified in PubMed for autosomal recessive nonsyndromic hearing loss 91. Research spans Diagnostic / Biomarker (50%) and Clinical Trial Publication (50%).
Qi J (2025). [PMID: 40603731](https://pubmed.ncbi.nlm.nih.gov/40603731/). *Nat Med*. [Clinical Trial Publication]
Hou W (2024). [PMID: 38977330](https://pubmed.ncbi.nlm.nih.gov/38977330/). *Nan Fang Yi Ke Da Xue Xue Bao*. [Diagnostic / Biomarker]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 9:31 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center